These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8077338)

  • 1. Inhibition of growth of the human malignant glioma cell line (U87MG) by the steroid hormone antagonist RU486.
    Pinski J; Halmos G; Shirahige Y; Wittliff JL; Schally AV
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1388-92. PubMed ID: 8077338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.
    Nordeen SK; Bona BJ; Moyer ML
    Mol Endocrinol; 1993 Jun; 7(6):731-42. PubMed ID: 8395651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone.
    Langeveld CH; van Waas MP; Stoof JC; Sutanto W; de Kloet ER; Wolbers JG; Heimans JJ
    J Neurosci Res; 1992 Mar; 31(3):524-31. PubMed ID: 1640503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo.
    Gabryś D; Dörfler A; Yaromina A; Hessel F; Krause M; Oertel R; Baumann M
    Strahlenther Onkol; 2008 Jan; 184(1):48-53. PubMed ID: 18188523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells.
    Kamradt MC; Mohideen N; Vaughan AT
    Gynecol Oncol; 2000 Apr; 77(1):177-82. PubMed ID: 10739708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced growth inhibition and differentiation of a human megakaryoblastic leukemia cell line: involvement of glucocorticoid receptor.
    Song LN; Cheng T
    Stem Cells; 1993 Jul; 11(4):312-8. PubMed ID: 8401254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effect of mifepristone (RU486) on human neuroblastoma cells (SK-N-SH): in vitro and in vivo studies.
    Casulari LA; Dondi D; Pratesi G; Piva F; Milani M; Piccolella M; Maggi R
    Braz J Med Biol Res; 2020; 53(11):e10067. PubMed ID: 33053110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
    Thomas M; Monet JD
    J Clin Endocrinol Metab; 1992 Sep; 75(3):865-70. PubMed ID: 1517379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding studies of RU486 in different Reuber hepatoma variants.
    Chasserot-Golaz S; Beck G
    Receptor; 1993; 3(1):31-7. PubMed ID: 8348081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted exposure radiosensitization of experimental human malignant glioma.
    Williams JA; Williams JR; Yuan X; Dillehay LE
    Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of growth 4 induces growth suppression and apoptosis in glioma U87MG.
    Li X; Cai L; Chen H; Zhang Q; Zhang S; Wang Y; Dong Y; Cheng H; Qi J
    Pathobiology; 2009; 76(4):181-92. PubMed ID: 19571607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor A-chain synthetic peptide inhibits human glioma xenograft proliferation in nude mice.
    Khachigian LM; Field SL; Crouch R; Chesterman CN
    Anticancer Res; 1995; 15(2):337-41. PubMed ID: 7763003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
    J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro growth stimulation of murine hepatoma cells by glucocorticoid.
    Lui WY; Chi CW; Chang YF; Chu HW; Hsieh CC; Yin PH; Liu TY; Ou YR; P'eng FK
    Anticancer Res; 2002; 22(3):1413-22. PubMed ID: 12168818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the anti-glucocorticosteroid effect of RU486 on the growth of mouse fibroblasts in culture by the immunosuppressor kf506]].
    Jung-Testas I; Delespierre B; Baulieu EE
    C R Acad Sci III; 1993 Dec; 316(12):1495-9. PubMed ID: 7522119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor.
    Bardon S; Vignon F; Chalbos D; Rochefort H
    J Clin Endocrinol Metab; 1985 Apr; 60(4):692-7. PubMed ID: 3972969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27.
    Schrappe M; Bumol TF; Apelgren LD; Briggs SL; Koppel GA; Markowitz DD; Mueller BM; Reisfeld RA
    Cancer Res; 1992 Jul; 52(14):3838-44. PubMed ID: 1617657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative action of the steroid RU486 in cultured human lymphoma cells.
    Schuster C; Chasserot-Golaz S; Beck G
    Cancer Lett; 1993 Jul; 71(1-3):43-50. PubMed ID: 8364897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.